vs
Side-by-side financial comparison of CARTERS INC (CRI) and Dexcom (DXCM). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $757.8M, roughly 1.7× CARTERS INC). Dexcom runs the higher net margin — 21.2% vs 1.5%, a 19.7% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -0.1%).
Carter's, Inc. is a major American designer and marketer of children's apparel. It was founded in 1865 by William Carter.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
CRI vs DXCM — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $757.8M | $1.3B |
| Net Profit | $11.6M | $267.3M |
| Gross Margin | 45.1% | 62.9% |
| Operating Margin | 3.8% | 25.6% |
| Net Margin | 1.5% | 21.2% |
| Revenue YoY | -0.1% | 21.6% |
| Net Profit YoY | -80.1% | 153.6% |
| EPS (diluted) | $0.32 | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | — | $1.3B | ||
| Q3 25 | $757.8M | $1.2B | ||
| Q2 25 | $585.3M | $1.2B | ||
| Q1 25 | $629.8M | $1.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $994.2M | ||
| Q2 24 | — | $1.0B |
| Q1 26 | — | $267.3M | ||
| Q4 25 | — | $267.3M | ||
| Q3 25 | $11.6M | $283.8M | ||
| Q2 25 | $446.0K | $179.8M | ||
| Q1 25 | $15.5M | $105.4M | ||
| Q4 24 | — | $151.7M | ||
| Q3 24 | — | $134.6M | ||
| Q2 24 | — | $143.5M |
| Q1 26 | — | 62.9% | ||
| Q4 25 | — | 62.9% | ||
| Q3 25 | 45.1% | 60.5% | ||
| Q2 25 | 48.1% | 59.5% | ||
| Q1 25 | 46.2% | 56.9% | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | — | 59.7% | ||
| Q2 24 | — | 62.4% |
| Q1 26 | — | 25.6% | ||
| Q4 25 | — | 25.6% | ||
| Q3 25 | 3.8% | 20.1% | ||
| Q2 25 | 0.7% | 18.4% | ||
| Q1 25 | 4.1% | 12.9% | ||
| Q4 24 | — | 17.0% | ||
| Q3 24 | — | 15.3% | ||
| Q2 24 | — | 15.7% |
| Q1 26 | — | 21.2% | ||
| Q4 25 | — | 21.2% | ||
| Q3 25 | 1.5% | 23.5% | ||
| Q2 25 | 0.1% | 15.5% | ||
| Q1 25 | 2.5% | 10.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.5% | ||
| Q2 24 | — | 14.3% |
| Q1 26 | — | $0.67 | ||
| Q4 25 | — | $0.67 | ||
| Q3 25 | $0.32 | $0.70 | ||
| Q2 25 | $0.01 | $0.45 | ||
| Q1 25 | $0.43 | $0.27 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | — | $0.34 | ||
| Q2 24 | — | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $184.2M | $917.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $864.6M | $2.7B |
| Total Assets | $2.5B | $6.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $917.7M | ||
| Q4 25 | — | $917.7M | ||
| Q3 25 | $184.2M | $1.8B | ||
| Q2 25 | $338.2M | $1.2B | ||
| Q1 25 | $320.8M | $904.9M | ||
| Q4 24 | — | $606.1M | ||
| Q3 24 | — | $621.2M | ||
| Q2 24 | — | $939.2M |
| Q1 26 | — | $2.7B | ||
| Q4 25 | — | $2.7B | ||
| Q3 25 | $864.6M | $2.7B | ||
| Q2 25 | $853.9M | $2.6B | ||
| Q1 25 | $847.2M | $2.3B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.4B |
| Q1 26 | — | $6.3B | ||
| Q4 25 | — | $6.3B | ||
| Q3 25 | $2.5B | $7.5B | ||
| Q2 25 | $2.5B | $7.3B | ||
| Q1 25 | $2.3B | $6.8B | ||
| Q4 24 | — | $6.5B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-128.0M | — |
| Free Cash FlowOCF − Capex | $-144.1M | — |
| FCF MarginFCF / Revenue | -19.0% | — |
| Capex IntensityCapex / Revenue | 2.1% | — |
| Cash ConversionOCF / Net Profit | -11.04× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $294.0M | ||
| Q3 25 | $-128.0M | $659.9M | ||
| Q2 25 | $40.3M | $303.0M | ||
| Q1 25 | $-48.6M | $183.8M | ||
| Q4 24 | — | $301.4M | ||
| Q3 24 | — | $199.5M | ||
| Q2 24 | — | $279.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $192.1M | ||
| Q3 25 | $-144.1M | $579.4M | ||
| Q2 25 | $24.1M | $208.9M | ||
| Q1 25 | $-59.0M | $96.8M | ||
| Q4 24 | — | $176.8M | ||
| Q3 24 | — | $88.3M | ||
| Q2 24 | — | $213.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 15.3% | ||
| Q3 25 | -19.0% | 47.9% | ||
| Q2 25 | 4.1% | 18.1% | ||
| Q1 25 | -9.4% | 9.3% | ||
| Q4 24 | — | 15.9% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | — | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 8.1% | ||
| Q3 25 | 2.1% | 6.7% | ||
| Q2 25 | 2.8% | 8.1% | ||
| Q1 25 | 1.6% | 8.4% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.10× | ||
| Q3 25 | -11.04× | 2.33× | ||
| Q2 25 | 90.37× | 1.69× | ||
| Q1 25 | -3.13× | 1.74× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRI
| Sales Channel Directly To Consumer | $362.3M | 48% |
| Sales Channel Through Intermediary | $283.8M | 37% |
| Other | $110.4M | 15% |
| Gift Cards | $1.3M | 0% |
DXCM
Segment breakdown not available.
